Nacre Capital

Nacre Capital is a global venture builder that focuses on creating and scaling startups using deep technology and hard science to tackle significant societal challenges. Established in 2007, the company operates from its headquarters in New York and Malta. Nacre Capital employs a hands-on approach, combining research and development, business development, and strategic partnerships to turn innovative ideas into successful enterprises. The company provides comprehensive support for startups, including incubation and R&D, business development, global scaling, and talent acquisition. Nacre Capital's portfolio features companies across various sectors, particularly in AI-driven solutions and biotechnology. Notable portfolio companies include FDNA, which uses AI for diagnosing genetic disorders, Seed-X, which develops AI-powered agricultural technologies, and Fairtility, which enhances IVF success rates through AI solutions. Nacre Capital aims to drive innovation by collaborating with scientists, technologists, and entrepreneurs.